When the world’s first pure play publicly listed psychedelic medicine company – Mind Medicine Inc. (MMED:NEO – NEO is a Canadian exchange) listed in early March, the stock soared. It was up 300% in its first three days of trading. Of course, the Market crash in the last few days has brought the stock down. But it’s a very encouraging early sign of investor interest…in what some believe will be the next stock market bubble. They announced TODAY that they are starting human trials on one of their products that they are hoping will be a cure for opioid addiction, and the stock is up 30% on volume. Several very astute investors—like Steve Cohen and Peter Thiel—have placed large bets in the psychedelics space. There have been some encouraging indications that psychedelics DO work as a medicine (=high efficacy). It reminds me of the monster returns generated by early investors in the cannabis space. Consider early cannabis industry entrant Canopy Growth (WEED:TSX) for instance: Rest of the story is here: https://investingwhisperer.com/investing-in-psychedelics/
hallucinating is the fun part. edit: the symbol is now MNMD. ---- Company Profile Mind Medicine (MindMed) Inc., formerly Broadway Gold Mining Ltd., is a neuro-pharmaceutical company. The Company discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The Company addresses the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine
